Efficacy and safety of Shenqi Dihuang decoction for lupus nephritis: A systematic review and meta-analysis
Journal of Ethnopharmacology · 2024-04 · 323 · 117602
DOI: 10.1016/j.jep.2023.117602 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Ethnopharmacology, 2024-04. Verfasst von Dan Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, 730000, China; Evidence-Based Medicine Center, S…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Lupus Erythematosus, Systemic, Lupus Nephritis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Lupus Nephritis (LN) is a serious complication of systemic lupus erythematosus (SLE). However, the treatment of lupus nephritis using traditional Chinese medicine remains controversial. AIM OF THE STUDY: To assess the efficacy and safety of Shenqi Dihuang decoction in the treatment of LN and review the clinical guidelines. MATERIALS AND METHODS: Six databases (China National Knowledge Infrastructure, Wanfang, PubMed, China Biology Medicine, the Cochrane Library, and Embase) were searched from their inception to September 10, 2022, for randomized controlled trials on the treatment of lupus nephritis using Shenqi Dihuang decoction. We conducted a meta-analysis of random effects using Review Manager 5.4 and assessed the certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. RESULTS: A total of 15,790 citations were identified, from which 14 eligible randomized controlled trials that enrolled 1002 participants were selected for this systematic review. Low-to-moderate certainty of evidence indicated that when compared with Western medicine, Shenqi Dihuang decoction combined with Western medicine was associated with favorable effects on clinical efficacy (risk ratio (RR) = 1.25, 95% confidence interval (CI): 1.15-1.37), vascular endothelial growth factor (mean difference (MD) = -30.90, 95% CI: -40.18 to -21.63), serum level (MD = -4.81 μmol L-1, 95% CI: -17.14 to 7.53), complement C3 (MD = -0.14 g L-1, 95% CI: -0.23 to -0.04), erythrocyte sedimentation rate (MD = -11.87 mm h-1, 95% CI: -22.01 to -1.73), and SLE disease activity score (MD = -3.38, 95% CI: -4.15 to -2.61), and exhibited a lower risk of infection (RR = 0.2, 95% CI: 0.05-0.90), gastrointestinal reaction (RR = 0.47, 95% CI: 0.17-1.28), and insomnia (RR = 0.29, 95% CI: 0.09-0.92). CONCLUSIONS: This systematic review provides a potential reference for understanding the efficacy and safety of Shenqi Dihuang decoction combined with Western medicine for treating patients with lupus nephritis. However, owing to the limited quality of the studies included in this review, lack of mycophenolate mofetil control, and high heterogeneity among the included studies, the current findings should be interpreted with caution. Therefore, the efficacy and safety of Shenqi Dihuang decoction in patients with PN still require further verification through future high-quality clinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, 730000, China; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000,…
- Department of Prenatal Diagnosis Center, Gansu Provincial Maternity and Child-care Hospital, Lanzhou, 730000, China.
- Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, China.
- Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, 730000, China.
- Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, 730000, China; Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, 730000,…
Zitieren
APA
Li, D., Pan, B., Ma, N., Wang, X., Deng, X., Lai, H., Ge, L., Niu, J., & Yang, K. (2024). Efficacy and safety of Shenqi Dihuang decoction for lupus nephritis: A systematic review and meta-analysis. Journal of Ethnopharmacology, 323, 117602. https://doi.org/10.1016/j.jep.2023.117602
Vancouver
Li D, Pan B, Ma N, Wang X, Deng X, Lai H, et al. Efficacy and safety of Shenqi Dihuang decoction for lupus nephritis: A systematic review and meta-analysis. Journal of Ethnopharmacology. 2024;323:117602. doi:10.1016/j.jep.2023.117602
BibTeX
@article{Li2024,
author = {Li, Dan and Pan, Bei and Ma, Ning and Wang, Xiaoman and Deng, Xiyuan and Lai, Honghao and Ge, Long and Niu, Junqiang and Yang, Kehu},
title = {Efficacy and safety of Shenqi Dihuang decoction for lupus nephritis: A systematic review and meta-analysis},
journal = {Journal of Ethnopharmacology},
year = {2024},
volume = {323},
pages = {117602},
doi = {10.1016/j.jep.2023.117602}
}
EUVIMED